Effects of Phase III Cardiac Rehabilitation on Mortality and Cardiovascular Events in Elderly Patients With Stable Coronary Artery Disease

被引:19
|
作者
Onishi, Tomo [1 ,3 ]
Shimada, Kazunori [1 ,3 ]
Sato, Hiroyuki [2 ,3 ]
Seki, Eriko [1 ]
Watanabe, Yoshiro [1 ]
Sunayama, Satoshi [1 ]
Ohmura, Hirotoshi [1 ]
Masaki, Yoshiyuki [1 ]
Nishitani, Miho [1 ]
Fukao, Kosuke [1 ]
Kume, Atsumi [1 ]
Sumide, Takahiro [3 ]
Mokuno, Hiroshi [1 ]
Naito, Hisashi [3 ,4 ]
Kawai, Sachio [1 ,4 ]
Daida, Hiroyuki [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Gen Med, Tokyo 1138421, Japan
[3] Juntendo Univ Hosp, Juntendo Sports Clin, Tokyo, Japan
[4] Juntendo Univ, Sch Hlth & Sports Sci, Dept Sports Sci, Chiba, Japan
基金
日本学术振兴会;
关键词
Cardiovascular events; Cardiac rehabilitation; Coronary artery disease; Elderly patients; Prognosis; QUALITY-OF-LIFE; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CLINICAL-TRIAL; PROGRAM J-CARP; RISK-FACTORS; EXERCISE CAPACITY; BEHAVIORAL-CHARACTERISTICS; HEART-DISEASE; FOLLOW-UP; JAPAN;
D O I
10.1253/circj.CJ-09-0638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiac rehabilitation (CR) has numerous benefits, including reduction of mortality and cardiovascular events, in patients with coronary artery disease (CAD). However, the long-term effect of phase III CR in elderly patients with stable CAD is still unknown. Methods and Results: The 111 elderly male CAD patients (65 years), including 37 subjects participating in supervised CR for 6 months and 74 age-matched controls, were analyzed. The patients were followed for up to 3,500 days, until the occurrence of death or 1 of the following major adverse cardiovascular events (MACE): cardiovascular death, acute coronary syndrome, refractory angina requiring revascularization, admission for congestive heart failure, or stroke. All-cause mortality tended to be lower in the CR group than in the Control group (14% vs 28%, P=0.081). The MACE incidence was significantly lower in the CR group than in the Control group (30% vs 62%, P=0.001). Multivariate Cox proportional hazard analysis showed that the MACE incidence was significantly lower in the CR group than in the Control group [adjusted hazard ratio 0.43 (95% confidence interval 0.20-0.91), P=0.027]. Conclusions: Phase III CR has the beneficial effect of reducing cardiovascular events even in elderly patients with stable CAD. (Circ J 2010; 74: 709-714)
引用
收藏
页码:709 / 714
页数:6
相关论文
共 50 条
  • [41] Effects of nicorandil on cardiovascular events in patients with coronary artery disease from the Japanese Coronary Artery Disease (JCAD) study
    Horinaka, S.
    Yabe, A.
    Yagi, H.
    Hara, H.
    Natsuoka, H.
    Yamazaki, T.
    Suzuki, S.
    Kohro, T.
    Nagai, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 454 - 454
  • [42] Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease
    Lavie, CJ
    Milani, RV
    CHEST, 1996, 109 (01) : 52 - 56
  • [43] Growth-Differentiation Factor-15 is an Independent Predictor of Cardiovascular Events and Mortality in Patients with Stable Coronary Artery Disease
    Kempf, Tibor
    Sinning, Jan-Malte
    Quint, Anja
    Bickel, Christoph
    Sinning, Christoph
    Wild, Philipp S.
    Schnabel, Renate
    Lubos, Edith
    Rupprecht, Hans J.
    Muenzel, Thomas
    Drexler, Helmut
    Blankenberg, Stefan
    Wollert, Kai C.
    CIRCULATION, 2008, 118 (18) : S1132 - S1132
  • [44] Effects of Cardiovascular Rehabilitation on Myocardial Perfusion and Functional Exercise Capacity in Patients With Stable Coronary Artery Disease and Myocardial Ischemia
    Mazzucco, Guillermo
    Pilon, Leonardo
    Torres-Castro, Rodrigo
    Lista-Paz, Ana
    Lopez, Silvana
    Chichizola, Nicolas
    Zapata, Gerardo
    Lopez, Jorge
    Berenguel-Senen, Alejandro
    Arbillaga-Etxarri, Ane
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2025, 45 (02) : 132 - 138
  • [45] Prevention of cardiac events in coronary artery disease patients
    Fox, K
    JOURNAL OF HYPERTENSION, 2004, 22 : S407 - S408
  • [46] Apolipoprotein E polymorphism predicts cardiovascular events in patients with stable multivessel coronary artery disease
    Lopes, N. H.
    Ferri, L. A. F.
    Lima, E. G.
    Vieira, R. D.
    Soares, P. R.
    Cesar, L. A.
    Hueb, W.
    Kriger, J. E.
    Pereira, A. C.
    Ramires, J. A. F.
    EUROPEAN HEART JOURNAL, 2009, 30 : 63 - 63
  • [47] Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain
    Kammerlander, Andreas A.
    Mayrhofer, Thomas
    Ferencik, Maros
    Pagidipati, Neha J.
    Karady, Julia
    Ginsburg, Geoffrey S.
    Lu, Michael T.
    Bittner, Daniel O.
    Puchner, Stefan B.
    Bihlmeyer, Nathan A.
    Meyersohn, Nandini M.
    Emami, Hamed
    Shah, Svati H.
    Douglas, Pamela S.
    Hoffmann, Udo
    DIABETES CARE, 2021, 44 (04) : 1038 - 1045
  • [48] Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients
    Paszek, Elzbieta
    Pociask, Elzbieta
    Zabczyk, Michal
    Piorkowski, Adam
    Butenas, Saulius
    Legutko, Jacek
    Undas, Anetta
    ATHEROSCLEROSIS, 2022, 346 : 124 - 132
  • [49] Interleukin-6 and the risk of future cardiovascular events in patients with stable coronary artery disease
    Fisman, E.
    Behar, S.
    Esper, R. J.
    Benderly, M.
    Boyko, V.
    Adler, Y.
    Tanne, D.
    Tenenbaum, A.
    EUROPEAN HEART JOURNAL, 2006, 27 : 671 - 671
  • [50] Laughter therapy cardiac rehabilitation in patients with stable coronary artery disease: a randomized clinical trial
    Saffi, M.
    Franzoni, L.
    Nery, R.
    Da Silveira, A. Donelli
    Andrade, C.
    Carvalho, G.
    Stein, R.
    EUROPEAN HEART JOURNAL, 2023, 44